Benzophenone derivatives as cysteine protease inhibitors and biological activity against Leishmania (L.) amazonensis amastigotes

被引:24
作者
de Almeida, Leticia [1 ]
Alves, Karina Ferreira [1 ]
Maciel-Rezende, Claudia Mara [2 ]
Jesus, Larissa de Oliveira Passos [3 ]
Pires, Francieli Ribeiro [2 ]
Viegas Junior, Claudio [2 ]
Izidoro, Mario Augusto [4 ]
de Souza Judice, Wagner Alves [3 ]
dos Santos, Marcelo Henrique [2 ]
Marques, Marcos Jose [1 ]
机构
[1] Univ Fed Alfenas, Inst Ciencias Biomed, Lab Biol Mol Microorganismos, BR-37130000 Alfenas, MG, Brazil
[2] Univ Fed Alfenas, Inst Quim, Lab Fitoquim & Quim Med, BR-37130000 Alfenas, MG, Brazil
[3] Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, BR-08780911 Mogi Das Cruzes, SP, Brazil
[4] Univ Sao Paulo, Dept Microbiol Imunol & Parasitol, Lab Biol Celular Parasitas, BR-04039032 Sao Paulo, SP, Brazil
关键词
Leishmania amazonensis; Benzophenone derivatives; Cysteine proteases; GARCINIA-BRASILIENSIS; TRYPANOSOMA-CRUZI; MEXICANA; PROTEINASES; VIRULENCE; CPB; SPECIFICITIES; PEPTIDASES; EXPRESSION; AUTOPHAGY;
D O I
10.1016/j.biopha.2015.08.030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The leishmanicidal potential of benzophenones has been described, some of them highlighting their potential as cysteine protease inhibitors. Therefore, this work described leishmanicidal activity of nine benzophenone derivatives (1a-c; 2a-c; 3a-c) against intramacrophage amastigote forms of Leishmania (L.) amazonensis (IC50) and the cytotoxic effect on murine peritoneal macrophages (CC50). The derivative 1c exhibited a selectivity index SI (CC50/IC50) of 6.7, besides cytotoxicity lower than Amphotericin B (p < 0.05). Moreover it showed inhibitory activity against papain (42.8 +/- 0.3, p < 0.05), and when tested on trypanosomatids cysteine proteases 1c also proved to be a potent inhibitor of rCPB2.8, rCPB3.0 and cruzain, showing non-competitive inhibition mechanism by enzymatic assays in vitro. So, benzophenone 1c is interesting drug candidate prototype, with a multi-target directed mode of action, inhibiting rCPB2.8, rCPB3.0 and cruzain. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 34 条
[1]   The peptidases of Trypanosoma cruzi: Digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death [J].
Alvarez, Vanina E. ;
Niemirowicz, Gabriela T. ;
Cazzulo, Juan J. .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2012, 1824 (01) :195-206
[2]   Analysis of the S2 subsite specificities of the recombinant cysteine proteinases CPB of Leishmania mexicana, and cruzain of Trypanosoma cruzi, using fluorescent substrates containing non-natural basic amino acids [J].
Alves, LC ;
Melo, RL ;
Cezari, MHS ;
Sanderson, SJ ;
Mottram, JC ;
Coombs, GH ;
Juliano, L ;
Juliano, MA .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2001, 117 (02) :137-143
[3]   Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor [J].
Assis, Diego Magno ;
Gontijo, Vanessa Silva ;
Pereira, Ivan de Oliveira ;
Nogueira Santos, Jorge Alexandre ;
Camps, Ihosvany ;
Nagem, Tanus Jorge ;
Ellena, Javier ;
Izidoro, Mario Augusto ;
dos Santos Tersariol, Ivarne Luis ;
Tenorio de Barros, Nilana Meza ;
Doriguetto, Antonio Carlos ;
dos Santos, Marcelo Henrique ;
Juliano, Maria Aparecida .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2013, 28 (04) :661-670
[4]   Complexities of Assessing the Disease Burden Attributable to Leishmaniasis [J].
Bern, Caryn ;
Maguire, James H. ;
Alvar, Jorge .
PLOS NEGLECTED TROPICAL DISEASES, 2008, 2 (10)
[5]   Overexpression of the Natural Inhibitor of Cysteine Peptidases in Leishmania mexicana Leads to Reduced Virulence and a Th1 Response [J].
Bryson, Karen ;
Besteiro, Sebastien ;
McGachy, H. Adrienne ;
Coombs, Graham H. ;
Mottram, Jeremy C. ;
Alexander, James .
INFECTION AND IMMUNITY, 2009, 77 (07) :2971-2978
[6]   Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials [J].
Creek, Darren J. ;
Charman, William N. ;
Chiu, Francis C. K. ;
Prankerd, Richard J. ;
Dong, Yuxiang ;
Vennerstrom, Jonathan L. ;
Charman, Susan A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) :1291-1296
[7]   Leishmaniasis chemotherapy-challenges and opportunities [J].
Croft, S. L. ;
Olliaro, P. .
CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (10) :1478-1483
[8]  
Das P, 2013, INDIAN J BIOCHEM BIO, V50, P363
[9]  
Dixon M., 1964, ENZYMES
[10]  
Dos Santos Andre Luis Souza, 2011, World J Biol Chem, V2, P48, DOI 10.4331/wjbc.v2.i3.48